FDA says new cyclospora outbreak linked to unspecified product
She typically covers breaking news, extreme weather and climate. Emily Mae previously wrote for outlets like the Los Angeles Times, BuzzFeed and Newsweek. Read Full Bio Emily Mae Czachor Updated on: July 24, 2026 / 9:47 AM EDT / CBS News Add CBS News on Google Federal health officials have identified a new cyclospora outbreak stemming from an unspecified product, the U.S.
- ▪She typically covers breaking news, extreme weather and climate.
- ▪Emily Mae previously wrote for outlets like the Los Angeles Times, BuzzFeed and Newsweek.
- ▪Read Full Bio Emily Mae Czachor Updated on: July 24, 2026 / 9:47 AM EDT / CBS News Add CBS News on Google Federal health officials have identified a new cyclospora outbreak stemming from an unspecified product, the U.S.
2 outlets in our directory ran this story, first to last over 1 hour. All of the coverage we found sits in one bucket: lean left. That one-sidedness is itself worth noticing.
- ▪ Confusing product recall adds to US cyclospora outbreak uncertainty — The Guardian — World
CBS News — US files mainly under news. We currently carry 43 of its stories.
Opening excerpt (first ~120 words) tap to expand
HealthWatch FDA reports new cyclospora outbreak linked to unspecified product as North Carolina probes cilantro, parsley .chip { background-image: url('/fly/bundles/cbsnewscore/images/chip-bgd/chip-bgd-healthwatch.jpg'); } By Emily Mae Czachor Emily Mae Czachor News Editor Emily Mae Czachor is a reporter and news editor at CBSNews.com. She typically covers breaking news, extreme weather and climate. Emily Mae previously wrote for outlets like the Los Angeles Times, BuzzFeed and Newsweek. Read Full Bio Emily Mae Czachor Updated on: July 24, 2026 / 9:47 AM EDT / CBS News Add CBS News on Google Federal health officials have identified a new cyclospora outbreak stemming from an unspecified product, the U.S. Food and Drug Administration said Thursday.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at CBS News — US.
Discussion
0 commentsMore from CBS News — US
